This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




Text Version   RSS   Subscribe   Unsubscribe   Archive   Media Kit          August 12, 2014

Home  |   About ASHI  |   Education  |   Publications  |   Meetings  |   Careers  |   News  |   Lab Center


 


ASSOCIATION NEWS

2014 revisions to 2013 ASHI Standards — now open for public comment
ASHI
The Quality Assurance and Standards Committee (QAS) has been working on updates to the 2013 ASHI Standards. There have been a variety of revisions recommended, but we wish to draw your particular attention to the following:
  • D.5.2.11 - "Laboratories Performing RFLP methods" has been deleted and in its place a new section on Next Generation Sequencing (NGS) has been added.
  • A number of new definitions pertaining to NGS have been added to the glossary.
  • D.5.3.8 - A new section on Virtual Crossmatching has been added.
  • All of the guidance sections now have reference numbers.
These proposed changes to the Standards have been submitted to the ASHI Board and the Accreditation Review Board (ARB) for review and comment. Now we seek your comments and suggestions.

Click here to view a redline version of the proposed 2014 Standards. Please carefully consider these proposed changes to the current standards and send your comments to Leslie Clark at ASHI Headquarters no later than Sept. 5.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


ASHI Quarterly quiz deadline — Sept. 1
ASHI
Please note that the ASHI Quarterly quiz deadline and identification number were inadvertently left off the second quarter issue that was recently mailed out. The deadline to submit your quiz answers is Sept. 1, and the identification number is 38-2-2014.

We apologize for any confusion.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Annual meeting registration is open!
ASHI
Click here to register now.

New this year! Join ASHI while registering for the meeting and save up to $135 on registration fees. Members who join now are paid through December 2015.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


INDUSTRY NEWS


Predictors of successful transplantation for severe combined immunodeficiency
2 Minute Medicine
SCID refers to a group of conditions in which both components of the body’s adaptive immune system — T-cells and B-cells — do not function properly. Since the source of these defective immune cells is defective stem cells in the bone marrow, the treatment for SCID is to transplant healthy stem cells into the patient. For this study, the authors reviewed over 200 cases of SCID treated over a 10-year period from 2000 to 2009. They looked for factors which were associated with better survival after transplantation.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


New potential biomarker for alzheimer's discovered
Genetic Engineering & Biotechnology News
Scientists from the Boston University School of Medicine say they have found variants in a new gene, PLXNA4, which may increase the risk of developing Alzheimer's disease. The discovery of this novel genetic association may lead to new drug treatment options that target PLXNA4 specifically, according to the researchers whose findings appear in the Annals of Neurology.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Endoplasmic reticulum aminopeptidase 1 function and its pathogenic role in regulating innate and adaptive immunity in cancer and major histocompatibility complex class I-associated autoimmune diseases
Tissue Antigens (subscription required)
Major histocompatibility complex class I molecules present antigenic peptides on the cell surface to alert natural killer cells and CD8+ T-cells for the presence of abnormal intracellular events, such as virus infection or malignant transformation. The generation of antigenic peptides is a multistep process that ends with the trimming of N-terminal extensions in the endoplasmic reticulum by aminopeptidases ERAP1 and ERAP2.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
 



ASHI Insights
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Lauren Swan, Content Editor, 202.684.7496  
Contribute news


Learn how to add us to your safe sender list so our emails get to your inbox.

This edition of ASHI Insights was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
July 29, 2014
July 15, 2014
July 1, 2014





7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063